Allianz Asset Management
ACHN

Allianz Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Allianz Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-42,400
Closed -$457K – 2636
2015
Q4 		$457K Buy
+42,400
New +$385K ﹤0.01% 2212
2014
Q3 		– Sell
-97,000
Closed -$734K – 2402
2014
Q2 		$734K Sell
97,000
-287,300
-75% -$1.15M ﹤0.01% 1473
2014
Q1 		$1.26M Sell
384,300
-8,000
-2% -$28K ﹤0.01% 1341
2013
Q4 		$1.3M Buy
392,300
+105,000
+37% +$305K ﹤0.01% 1330
2013
Q3 		$868K Sell
287,300
-275,900
-49% -$1.89M ﹤0.01% 1404
2013
Q2 		$4.61M Buy
+563,200
New +$4.3M 0.01% 919

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's ACHN Position: Q1 2016 in Review

Allianz Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2016, closing a stake of 42,400 shares — an estimated $457K sold.

Allianz Asset Management first reported a position in ACHN in Q2 2013 and held it in 6 quarters. The position peaked at $4.61M in Q2 2013. 153 funds tracked by Wall St. Rank hold ACHN as of Q1 2016.

  • Allianz Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Allianz Asset Management sold 42,400 Achillion Pharmaceuticals shares in Q1 2016, an estimated $457K.
  • Allianz Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Allianz Asset Management's Achillion Pharmaceuticals position peaked at $4.61M in Q2 2013.
  • 153 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2016.

Based on Allianz Asset Management's 13F filing for Q1 2016, filed 13 May 2016.